$929 Million RSV Diagnostics Market by Product, Method, End User - Global Forecast to 2022 - ResearchAndMarkets.com

DUBLIN--()--The "RSV Diagnostics Market by Product (Kits and Assays, Instruments), Method (Rapid Antigen Detection Test, Molecular Diagnostic), End User (Hospitals & Clinics, Clinical Laboratories, Homecare) - Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.

The RSV Diagnostics Market is Expected to Reach USD 929.2 Million By 2022 from USD 574.3 Million in 2017, at a CAGR of 10.1%.

Factors driving the growth of this market include rising burden of RSV infections, growing demand for molecular diagnostic tests for the diagnosis of RSV infections, increasing adoption of point-of-care testing for RSV diagnosis and increasing approval of RSV diagnostic kits and assays. On the other hand, the development of RSV vaccine is expected to emerge as a biggest threat which would alter the market growth in the coming years.

The products market is further segmented into kits and assays, instruments, and other products. The kits and assays segment is expected to account for the largest share and grow at the highest CAGR during the forecast period. Factors driving the growth of this segment include the increasing infection of RSV in newborn infants and young children and growing demand for kits and assays for RSV diagnosis.

The method market is further segmented into Rapid Antigen Detection Tests, molecular diagnostics, and others methods. The molecular diagnostics segment is expected to account for the largest share of the global RSV diagnostics market in 2017. Market growth can largely be attributed to factors such as the increasing demand for molecular diagnostic testing for RSV diagnosis.

Geographically, the RSV diagnostics market is dominated by North America, followed by Europe in 2017. Asia Pacific is estimated to grow at the fastest rate, due to increasing infectious disease burden such as RSV infection, increasing demand for RSV disease diagnosis, and increasing healthcare expenditure in APAC countries.

The key players in the RSV diagnostics market include bioMrieux (France), Becton Dickinson (US), Abbott (US), Roche (Switzerland), Danaher (US), Thermo Fisher (US), Luminex (US), BioCartis (Belgium), Hologic (US), and Fast Track Diagnostics (Luxembourg).

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 RSV Diagnostics Market, By Product

7 RSV Diagnostics Market, By Method

8 RSV Diagnostics Market, By End User

9 RSV Diagnostics Market, By Region

10 Competitive Landscape

11 Company Profiles

  • Abbott
  • Becton, Dickinson and Company (BD)
  • Biocartis
  • Biomrieux
  • Danaher
  • Fast Track Diagnostics
  • Hologic
  • Luminex
  • Roche
  • Thermo Fisher

For more information about this report visit https://www.researchandmarkets.com/research/fjddt3/929_million_rsv?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Disease Testing

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Disease Testing